HIV GR: Peter W. Hunt, M.D.
BSRB 154 615 Charles E Young Dr S, Los Angeles"CMV, Aging, and HIV"
Dr. Hunt will review the evidence supporting a potential role of asymptomatic CMV co-infection as a driver of persistent immune dysfunction and morbidity and mortality in people treated with HIV. He will also describe exciting results from a recent clinical trial of letermovir supporting a causal role of CMV in these processes as well as functional aging outcomes in this setting. Important sex differences in the response to treating asymptomatic CMV in this setting will also be discussed.